Novo Nordisk Says Wegovy Maintenance Dose Of 2.4 Mg Will Be Available In Pharmacies In Germany For 301.91 Euros For 4 Weeks Of Treatment; Starter Dose Of 0.25 Mg Will Be Available In Pharmacies In Germany For 171.92 Euros For 4 Weeks Of Treatment
Portfolio Pulse from Charles Gross
Novo Nordisk announced that its prescription drug Wegovy will be available in German pharmacies by the end of July. The maintenance dose of 2.4 mg will cost 301.91 Euros for 4 weeks of treatment, while the starter dose of 0.25 mg will cost 171.92 Euros for 4 weeks of treatment.
July 14, 2023 | 8:54 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The availability of Novo Nordisk's Wegovy in Germany could potentially impact the German ETF (EWG).
As Novo Nordisk is a significant player in the pharmaceutical industry, the availability of its new product in Germany could potentially impact the German ETF (EWG), particularly if the product significantly boosts Novo Nordisk's revenues.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 60
POSITIVE IMPACT
Novo Nordisk's new product availability and pricing in Germany could potentially increase the company's revenues.
The availability of Novo Nordisk's Wegovy in Germany, one of the largest pharmaceutical markets in Europe, could potentially increase the company's revenues. The pricing of the drug also indicates a potential for significant revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100